DOCM Stock Overview
Operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
DocMorris AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 29.54 |
| 52 Week High | CHF 101.60 |
| 52 Week Low | CHF 28.56 |
| Beta | 1.4 |
| 11 Month Change | -18.53% |
| 3 Month Change | -24.10% |
| 1 Year Change | -44.58% |
| 33 Year Change | -91.93% |
| 5 Year Change | -68.81% |
| Change since IPO | -81.53% |
Recent News & Updates
DocMorris AG's (VTX:DOCM) Subdued P/S Might Signal An Opportunity
Oct 25
Does DocMorris (VTX:DOCM) Have A Healthy Balance Sheet?
Sep 22Recent updates
DocMorris AG's (VTX:DOCM) Subdued P/S Might Signal An Opportunity
Oct 25Does DocMorris (VTX:DOCM) Have A Healthy Balance Sheet?
Sep 22Would Zur Rose Group (VTX:ROSE) Be Better Off With Less Debt?
Sep 07We Think Zur Rose Group (VTX:ROSE) Has A Fair Chunk Of Debt
Dec 05We Think Zur Rose Group (VTX:ROSE) Has A Fair Chunk Of Debt
Aug 22Is Zur Rose Group (VTX:ROSE) Using Too Much Debt?
Apr 19Earnings Update: Zur Rose Group AG (VTX:ROSE) Just Reported And Analysts Are Trimming Their Forecasts
Mar 22Some Zur Rose Group AG (VTX:ROSE) Analysts Just Made A Major Cut To Next Year's Estimates
Mar 20What Kind Of Investors Own Most Of Zur Rose Group AG (VTX:ROSE)?
Feb 23Is Zur Rose Group's (VTX:ROSE) Share Price Gain Of 210% Well Earned?
Jan 19Zur Rose Group AG (VTX:ROSE) Is Expected To Breakeven In The Near Future
Dec 15Shareholder Returns
| DOCM | CH Consumer Retailing | CH Market | |
|---|---|---|---|
| 7D | -12.0% | 0.6% | 0.6% |
| 1Y | -44.6% | 3.3% | 5.8% |
Return vs Industry: DOCM underperformed the Swiss Consumer Retailing industry which returned 3.3% over the past year.
Return vs Market: DOCM underperformed the Swiss Market which returned 5.8% over the past year.
Price Volatility
| DOCM volatility | |
|---|---|
| DOCM Average Weekly Movement | 8.7% |
| Consumer Retailing Industry Average Movement | 4.0% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in CH Market | 6.6% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: DOCM's share price has been volatile over the past 3 months compared to the Swiss market.
Volatility Over Time: DOCM's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swiss stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 1,453 | Walter Hess | corporate.docmorris.com/en |
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products. It also provides professional health care services.
DocMorris AG Fundamentals Summary
| DOCM fundamental statistics | |
|---|---|
| Market cap | CHF 380.97m |
| Earnings (TTM) | -CHF 97.26m |
| Revenue (TTM) | CHF 1.00b |
0.4x
P/S Ratio-3.9x
P/E RatioIs DOCM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DOCM income statement (TTM) | |
|---|---|
| Revenue | CHF 1.00b |
| Cost of Revenue | CHF 792.13m |
| Gross Profit | CHF 210.66m |
| Other Expenses | CHF 307.92m |
| Earnings | -CHF 97.26m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 13, 2025
| Earnings per share (EPS) | -7.54 |
| Gross Margin | 21.01% |
| Net Profit Margin | -9.70% |
| Debt/Equity Ratio | 93.8% |
How did DOCM perform over the long term?
See historical performance and comparison